Highly selective nonsteroidal anti-inflammatory drugs in the prevention of postoperative pain symptoms

Author:

Iordanishvili Andrey K.ORCID,Shvetsov Mikhail M.ORCID

Abstract

BACKGROUND: Patients often visit healthcare institutions for the treatment of various diseases, which are accompanied by painful symptoms. Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for the prevention and relief of pain symptoms in surgical and trauma departments, providing good clinical results and analgesic effects. AIM: This study aimed to evaluate the effectiveness of etoricoxib at various dosages for the prevention of pain symptoms after complex removal of the lower wisdom teeth. MATERIAL AND METHODS: The patients were 108 (67 men and 41 women) young people (1832 years old) who underwent a complex removal of an impacted and/or dystopic lower wisdom tooth for orthodontic indications. During the clinical study, the patients were divided into five groups depending on the use and dosage of the highly selective NSAID etoricoxib. RESULTS: In the clinical study, etoricoxib was used at dosages of 30, 60, 90, and 120 mg to prevent pain in 108 patients aged 1832 years who underwent complex removal of the lower wisdom teeth according to orthodontic parameters. For these purposes, it is effective and sufficient to use the drug at a dosage of 60 mg. Etoricoxib also prevented the occurrence of infectious and inflammatory postoperative complications, such as alveolitis, and provided better patient tolerance to the surgical intervention. CONCLUSION: This clinical study on the effectiveness of etoricoxib at various dosages for the prevention of pain symptoms after removal the lower wisdom tooth showed the effectiveness of 60 mg, which should be taken 6090 min before surgery and in the next 23 days in the morning. Etoricoxib not only provided a significant reduction in pain intensity in the postoperative period but also prevented the occurrence of infectious and inflammatory postoperative complications and enabled better patient tolerance to the surgical intervention. Etoricoxib dosages of 90 mg and 120 mg are not advisable for the prevention of pain symptoms in surgical dentistry. Such dosages are necessary for complex treatment of dental diseases, accompanied by a chronic pain syndrome.

Publisher

ECO-Vector LLC

Reference17 articles.

1. Gaivoronskii IV, Iordanishvili AK, Vasil’chenko GA, et al. Retentsiya zubov mudrosti nizhnei chelyusti. Saint Petersburg: Nordmedizdat; 2011. 142 p. (In Russ).

2. Iordanishvili AK. Sovety vrachu-stomatologu po vypolneniyu in”ektsionnykh metodov obezbolivaniya na chelyustyakh. The Dental Institute. 2005;(2):64–65. (In Russ).

3. Patent RUS № 78669/ 10.12.2008. Byul. № 34. Gaivoronskii IV, Iordanishvili AK, Vasil’chenko GA. Elevator dlya udaleniya tret’ikh molyarov: patent na poleznuyu model’. Available from: https://rusneb.ru/catalog/000224_000128_0000078660_20081210_U1_RU/

4. Iordanishvili AK. Khirurgicheskoe lechenie periodontitov i kist chelyustei. Saint Petersburg: Nordmedizdat; 2000. 217 p. (In Russ).

5. Iordanishvili AK, Vasil’chenko GA, Sagalatyi AM, Il’ina OY. Medical, social and economic aspect of difficult eruption of the third molars abstract. The Dental Institute. 2011;(1):28–29. (In Russ).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3